NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 67 filers reported holding NOVOCURE LTD in Q3 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,578,840 | -74.7% | 221,600 | -35.1% | 0.00% | -70.0% |
Q2 2023 | $14,163,950 | -37.0% | 341,300 | -8.7% | 0.01% | -33.3% |
Q1 2023 | $22,486,346 | -20.0% | 373,900 | -2.4% | 0.02% | -25.0% |
Q4 2022 | $28,100,385 | -9.1% | 383,100 | -5.9% | 0.02% | -9.1% |
Q3 2022 | $30,928,000 | +9.2% | 407,048 | -0.1% | 0.02% | +15.8% |
Q2 2022 | $28,311,000 | -15.6% | 407,348 | +0.6% | 0.02% | 0.0% |
Q1 2022 | $33,533,000 | +26.0% | 404,748 | +14.2% | 0.02% | +18.8% |
Q4 2021 | $26,612,000 | -37.8% | 354,448 | -3.7% | 0.02% | -40.7% |
Q3 2021 | $42,756,000 | -48.7% | 368,048 | -2.1% | 0.03% | -47.1% |
Q2 2021 | $83,371,000 | +89.5% | 375,848 | +12.9% | 0.05% | +75.9% |
Q1 2021 | $43,990,000 | -21.7% | 332,800 | +2.6% | 0.03% | -27.5% |
Q4 2020 | $56,151,000 | +160.7% | 324,500 | +67.7% | 0.04% | +135.3% |
Q3 2020 | $21,538,000 | +92.1% | 193,500 | +2.3% | 0.02% | +88.9% |
Q2 2020 | $11,214,000 | +8.4% | 189,100 | +23.1% | 0.01% | -18.2% |
Q1 2020 | $10,343,000 | -18.4% | 153,600 | +2.1% | 0.01% | -15.4% |
Q4 2019 | $12,674,000 | +17.5% | 150,400 | +4.3% | 0.01% | +18.2% |
Q3 2019 | $10,783,000 | +20.6% | 144,200 | +2.0% | 0.01% | +10.0% |
Q2 2019 | $8,941,000 | +56.4% | 141,400 | +19.1% | 0.01% | +66.7% |
Q1 2019 | $5,718,000 | +49.2% | 118,700 | +3.7% | 0.01% | +20.0% |
Q4 2018 | $3,833,000 | -33.2% | 114,500 | +4.6% | 0.01% | -16.7% |
Q3 2018 | $5,738,000 | +67.4% | 109,500 | 0.0% | 0.01% | +50.0% |
Q2 2018 | $3,427,000 | +103.1% | 109,500 | +41.5% | 0.00% | +100.0% |
Q1 2018 | $1,687,000 | +13.3% | 77,400 | +5.0% | 0.00% | 0.0% |
Q4 2017 | $1,489,000 | +1.8% | 73,700 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,463,000 | +19.9% | 73,700 | +4.5% | 0.00% | +100.0% |
Q2 2017 | $1,220,000 | +113.7% | 70,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $571,000 | +3.3% | 70,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $553,000 | -8.1% | 70,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $602,000 | -26.9% | 70,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $823,000 | – | 70,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
Cortina Asset Management, LLC | 141,352 | $8,938,000 | 0.55% |